Natalie Sacks
Board Member
Caribou Biosciences, Inc. (CRBU)Equibles does not estimate personal net worth.
About Natalie Sacks
Natalie Sacks is recorded as Board Member at Caribou Biosciences, Inc. (CRBU). The newest filing on record that lists Natalie Sacks as Board Member at Caribou Biosciences, Inc. (CRBU) is dated April 24, 2026. Zymeworks Inc. reported in an 8-K filed June 29, 2023 that Natalie Sacks resigned as director, effective June 30, 2023. Caribou Biosciences, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Caribou Biosciences, Inc. includes Rachel Haurwitz (CEO and Board Member), Sriram Ryali (CFO), Tim Kelly (CTO) and 7 others.
“In addition, on June 26, 2023, Dr. Natalie Sacks submitted her resignation from the Board, including the nominating and corporate governance committee and the research and development committee of the Board, effective June 30, 2023.”
Affiliation history
-
Current
Start not stated–present
Last confirmed April 24, 2026
Company network
Leadership on record at Caribou Biosciences, Inc.
- Rachel Haurwitz CEO, Board Member
- Sriram Ryali CFO
- Tim Kelly CTO
- Jason V. O'Byrne Chief Accounting Officer
- Ryan Fischesser Chief Accounting Officer
- Andrew Guggenhime Board Member
- Dara Richardson-Heron Board Member
- Dara Richardson-Heron, M.D. Board Member
- David Johnson Board Member
- Nancy C. Whiting, Pharm. D. Board Member